Proteome Sciences plc (AIM:PRM)

Market Cap	9.12M
Revenue (ttm)	4.89M
Net Income (ttm)	-3.41M
Shares Out	295.18M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	217,375
Average Volume	297,006
Open	2.685
Previous Close	3.090
Day's Range	2.685 - 3.390
52-Week Range	2.218 - 5.400
Beta	-0.07
RSI	38.71
Earnings Date	Jun 13, 2025

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathw...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1993
• Employees: 36
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: PRM

Financial Performance

In 2024, Proteome Sciences's revenue was 4.89 million, a decrease of -2.80% compared to the previous year's 5.03 million. Losses were -3.41 million, 39.4% more than in 2023.